Insider filing · LGND
Nancy Ryan Gray
Director
profile →
Ligand Pharmaceuticals Incorporated
LGND · Healthcare · 37 filings in 24 months
ticker →
Nancy Ryan Gray sold $1.4M of Ligand Pharmaceuticals Incorporated (LGND)
Executed Nov 7 2025, disclosed Nov 12 2025, 5 days later.
Value, as filed
$1.4M
6,571 sh across 2 lots
Executed
Nov 7 2025
the trade date, as filed
Disclosed
Nov 12 2025
5 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
NGNancy Ryan Gray (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Ligand Pharmaceuticals Incorporated (LGND).
The name
LGNDHealthcare · Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→